MustGrow Commences Funded Study On Tobacco Crop Protection Program

MustGrow Biologics (CSE: MGRO) announced this morning the commencement of a tobacco crop protection research program. The program is being funded by the Canadian Tobacco Research Foundation, with the goal of targeting tobacco cyst nematodes and root-lesion nematodes.

A collaborative research program is currently underway between the foundation and MustGrow as a means of building on the firms previous achievements that include third party studies using MustGrow’s patented mustard-derived bio-pesticide that demonstrated 100% control of soil-borne diseases and pathogens that include nematodes. Corporate collaboration discussions with tobacco industry leaders are also underway.

The study will see MustGrow’s patented liquid format utilized for testing of effectiveness against the disease, whereas previous testing has largely focused on the granular product format. The use of liquid format enables the bio-pesticide to be applied via spraying, which is often a more favourable alternative for application. The product will be evaluated in both pre-planting and post-planting applications, targeting tobacco cyst nematodes after hatching.

Nematodes are parasitic worms that infect the root system of a plant, reducing water and nutrient movement within the plant and stunting growth, resulting in lower yields. Yield destruction from the parasite has been reported in eleven tobacco-producing countries, which includes both Canada and the US. Global tobacco crop loss from the parasite is estimated as being US$4.2 billion, or 15%. Nematodes continue to do this damage to tobacco plants despite the use of synthetic chemical pesticides, which continue to be deregistered or banned due to the harmful effects of such pesticides.

A timeline for the completion of the collaborative research program has not been provided, however the study is currently underway.

MustGrow Biologics last traded at $0.32 on the CSE.


FULL DISCLOSURE: MustGrow Biologics Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover MustGrow Biologics Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Leave a Reply

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

First Majestic Posts Record Cash Flows In Q1 As Production Costs Fall

Brazil Potash Secures Funding In Support Of US$2.5 Billion Autozales Project

Related News

MustGrow Biologics: NexusBioAg Partnership Validates Firms Research Program

Among current trends, governments around the world are banning the use of harmful pesticides and...

Monday, May 24, 2021, 02:16:00 PM

MustGrow Announces 100% Control Of Root Rot Disease With Patented Biopesticide

MustGrow Biologics (CSE: MGRO) has seen further success with its mustard-derived biopesticide, this morning announcing...

Wednesday, January 20, 2021, 07:58:22 AM

MustGrow Biologics To Raise $2.0 Million In Private Placement

MustGrow Biologics (CSE: MGRO) this morning announced it will be conducting a small financing. The...

Monday, September 13, 2021, 07:55:55 AM

MustGrow Enters Exclusive Marketing And Distribution Agreement With NexusBioAg

MustGrow Biologics (CSE: MGRO) has seen further validation of its tech this morning, with the...

Wednesday, July 20, 2022, 08:23:29 AM

MustGrow Biologics Sees Continued Positive Results From Field Trials For Banana Panama Disease

MustGrow Biologics (CSE: MGRO) has finally seen the results of its initial field trial program...

Wednesday, November 10, 2021, 08:01:52 AM